apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial (2016) Eigentler TK, Gutzmer R, Hauschild A, Heinzerling L, Schadendorf D, Nashan D, Hoelzle E, et al. Journal article Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy (2016) Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, et al. Journal article Preferences of German melanoma patients for interferon (IFN) ?-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy (2016) Kaehler KC, Blome C, Forschner A, Gutzmer R, Haalck T, Heinzerling L, Kornek T, et al. Journal article Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma (2016) Kaehler KC, Hassel JC, Heinzerling L, Loquai C, Moessner R, Ugurel S, Zimmer L, Gutzmer R Journal article Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma (2016) Kirchberger MC, Hauschild A, Schuler G, Heinzerling L Journal article Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy (2016) Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, et al. Journal article Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis (2016) Lankes K, Hundorfean G, Harrer T, Pommer AJ, Agaimy A, Angelovska I, Tajmir-Riahi A, et al. Journal article Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 (2016) Schoffer O, Schuelein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, et al. Journal article A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival (2015) Ugurel S, Loquai C, Kaehler K, Hassel J, Berking C, Zimmer L, Haubitz I, et al. Journal article Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries (2015) Behling J, Chan AK, Zeh C, Nekesa C, Heinzerling L Journal article